e. pei
DESCRIPTION
a. PEI. e. PEI. **. **. **. ****. *. ****. **. ****. **. ***. ***. *. ***. **. **. b. PLL. f. PLL. c. PLL-PA. g. PLL-PA. d. Lipofectamine. h. Lipofectamine. - PowerPoint PPT PresentationTRANSCRIPT
0
50
100
150
200
250
300
c-DNA (4) c-DNA (24) l-DNA (4) l-DNA (24) pcr-DNA (4) pcr-DNA (24)
mea
n f
luo
resc
ence
o
f C
y5.5
-la
bel
ed D
NA
+ serum- serum
0
50
100
150
200
250
300
c-DNA (4) c-DNA (24) l-DNA (4) l-DNA (24) pcr-DNA (4) pcr-DNA (24)m
ean
flu
ore
scen
ceo
f C
y5.5
-lab
eled
DN
A
+ serum- serum
0
50
100
150
200
250
300
c-DNA (4) c-DNA (24) l-DNA (4) l-DNA (24) pcr-DNA (4) pcr-DNA (24)
me
an
flu
ore
sc
en
ce
o
f C
y5
.5-l
ab
ele
d D
NA
+ serum- serum
0
50
100
150
200
250
300
c-DNA (4) c-DNA (24) l-DNA (4) l-DNA (24) pcr-DNA (4) pcr-DNA (24)
me
an
flu
ore
sc
en
ce
of
Cy
5.5
-la
be
led
DN
A
+ serum- serum
0
20
40
60
80
100
120
c-DNA (4) c-DNA (24) l-DNA (4) l-DNA (24) pcr-DNA (4) pcr-DNA (24)
per
cen
t o
f C
y5.5
po
siti
ve c
ells
+serum-serum
0
20
40
60
80
100
120
c-DNA (4) c-DNA (24) l-DNA (4) l-DNA (24) pcr-DNA (4) pcr-DNA (24)
per
cen
t o
f C
y5.5
po
siti
ve c
ells
+serum-serum
0
20
40
60
80
100
120
c-DNA (4) c-DNA (24) l-DNA (4) l-DNA (24) pcr-DNA (4) pcr-DNA (24)
pe
rce
nt
of
Cy
5.5
po
sit
ive
ce
lls +serum
-serum
0
20
40
60
80
100
120
c-DNA (4) c-DNA (24) l-DNA (4) l-DNA (24) pcr-DNA (4) pcr-DNA (24)
per
cen
t o
f C
y5.5
po
siti
ve c
ells
+serum-serum
e. PEI
f. PLL
g. PLL-PA
h. Lipofectamine
a. PEI
b. PLL
c. PLL-PA
d. Lipofectamine
*
* ***
****
**
****
**
***
**
**** ** **
*** ** **